Fuji Pharma (4554) · InitiativeAchieved
Securing Flexibility for Agile Capital Policy Through a Reduction in Capital Reserve
First written in FY2021. 1 of 2 entries say "Achieved", first in FY2022-Q1. Latest entry: FY2022-Q1.
2entries
2years
0from disclosures
How it moved
Same theme, other companies
Transfer to Other Capital Surplus Through Capital Reduction and Capital Structure ReorganizationA theme 203 companies write about · 0 as a headwind · 186 as a tailwind
118 other companies' latest entry also says "Achieved".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 198 companies compared. The sentences above are computed from all 198.Comparing 200 of the theme's 206 threads.Full recordFilings, disclosures and news, newest first
- FY2022-Q1AchievedAnnual report
「At the annual shareholders' meeting held on 17 December 2021, the company resolved to reduce its capital reserve, and the reduction took effect on 31 January 2022.」
States that the reduction involving the transfer of ¥4,408 million from the capital reserve to other capital surplus took effect on 31 January 2022 and that the measure was completed. - FY2021First statedAnnual report
「The company will reduce the amount of its capital reserve pursuant to Article 448, paragraph 1 of the Companies Act, in preparation for flexible capital policy going forward and to secure flexibility in its financial strategy.」
For the first time, discloses a measure to transfer ¥4,408 million from the capital reserve to other capital surplus, approved at the shareholders' meeting on 17 December 2021 and scheduled to take effect on 31 January 2022.